NCT06456424View on ClinicalTrials.gov

Bacteriophage Therapy for Methicillin-Sensitive Staphylococcus Aureus Prosthetic Joint Infection

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

November 20, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Prosthetic Joint Infections of HipStaphylococcus Aureus Infection
Interventions
BIOLOGICAL

Phage therapy

Bacteriophage cocktail consisting of phages BP13 and J1P3

Trial Locations (1)

T3M 1M4

South Health Campus, Calgary

Sponsors
All Listed Sponsors
collaborator

University of Toronto

OTHER

collaborator

Precisio Biotix Therapeutics, Inc.

INDUSTRY

lead

University of Calgary

OTHER

NCT06456424 - Bacteriophage Therapy for Methicillin-Sensitive Staphylococcus Aureus Prosthetic Joint Infection | Biotech Hunter | Biotech Hunter